Real-world treatment patterns and outcomes of triple-class treated patients with multiple myeloma in the United States
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2023.2154648
Abstract: ABSTRACT Objectives Although multiple myeloma (MM) survival has improved following the introduction of proteosome inhibitors, immunomodulatory drugs, and anti-CD38 therapies, patients become refractory to these agents. Real-world outcomes of triple-class exposed patients are limited and… read more here.
Keywords: exposure; outcomes triple; triple class; class ... See more keywords